These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1323919)

  • 21. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Introduction to Arduan].
    Acta Pharm Hung; 1992 May; 62(3):71-138. PubMed ID: 1323915
    [No Abstract]   [Full Text] [Related]  

  • 23. Determination of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in human serum.
    Szabó G; Tassonyi E
    Arzneimittelforschung; 1981; 31(6):1013-5. PubMed ID: 6266429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of pipecurium bromide in the rat.
    Bodrogi L; Fehér T; Váradi A; Vereczkey L
    Arzneimittelforschung; 1980; 30(2a):366-70. PubMed ID: 6248081
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between pipecuronium and suxamethonium in the dog.
    Jones RS
    Res Vet Sci; 1987 Nov; 43(3):308-12. PubMed ID: 2832912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative clinical study of pipecurium bromide and pancuronium bromide.
    Boros M; Szenohradszky J; Marosi G; Tóth I
    Arzneimittelforschung; 1980; 30(2a):389-93. PubMed ID: 6248087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arduan muscle relaxation prolonged with norcuron.
    Fister T
    Ther Hung; 1991; 39(3):125-7. PubMed ID: 1687841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with a new steroid muscle relaxant: pipecurium bromide.
    Bunjatjan AA; Miheev VI
    Arzneimittelforschung; 1980; 30(2a):383-5. PubMed ID: 6248085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis and pipecuronium--report of two cases.
    Naguib M; Sari-Kouzel A; Ashour M; Seraj M; Messahel F
    Middle East J Anaesthesiol; 1992 Feb; 11(4):381-90. PubMed ID: 1320731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of atracurium, pipecuronium, and vecuronium for tracheal intubation.
    Cozanitis DA; Hofmockel R; Benad G; Sitarek U
    Acta Anaesthesiol Belg; 1987; 38(1):77-81. PubMed ID: 2884796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arduan, a new neuromuscular blocking agent.
    Fister T
    Ther Hung; 1983; 31(3):117-9. PubMed ID: 6100827
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kinetic study of the hydrolysis of pipecuronium bromide. II. Specific acid-base catalysis].
    Kovács P; Takácsi Nagy G; Horváth P
    Acta Pharm Hung; 1983 Mar; 53(2):64-70. PubMed ID: 6310953
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-lasting neuromuscular blockade from pipecuronium.
    Caballero PA; Johnstone RE
    Anesthesiology; 1992 Jan; 76(1):154-5. PubMed ID: 1309627
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determinations of steroidal muscle relaxants and their metabolites].
    Fukushima K; Uchida K
    Masui; 1991 Jan; 40(1):101-4. PubMed ID: 1646899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On some properties of a new steroid curare-like compound pipecurium bromide.
    Alyautdin RN; Buyanov VV; Fisenko VP; Lemina EJ; Muratov VK; Samoilov DN; Shorr VA
    Arzneimittelforschung; 1980; 30(2a):355-7. PubMed ID: 6248077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of pipecurium bromide in rats.
    Vereczkey L; Szporny L
    Arzneimittelforschung; 1980; 30(2a):364-6. PubMed ID: 6248080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kinetic study of the hydrolysis of pipecuronium bromide. III. General acid-base catalysis, effect of the solvent on the rate of hydrolysis].
    Kovács P; Takácsi Nagy G; Horváth P
    Acta Pharm Hung; 1983 Mar; 53(2):71-85. PubMed ID: 6310954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.